Come and join us across the globe
Sign In

Pipeline SHIELD treatment of left anterior temporal mid M1-aneurysm

Last update on November 28, 2022

Find out how Dr Joseph P. Antonios treated a 67 year-old female  with multi-lobed 7mm left mid-M1 aneurysm 

Case presentation

Patient

67 year-old female on Xarelto for atrial fibrillation with history of multiple intracranial aneurysms, discovered during workup for right-sided strokes, and concern for multi-lobed 7mm left mid-M1 aneurysm. On DSA, noted that the anterior temporal artery arises from the proximal neck of the aneurysm.

 

 

Pipeline-SHIELD-treatment-of-left-anterior-temporal-mid-M1-aneurysm

 

 

 

Pipeline-SHIELD-treatment-of-left-anterior-temporal-mid-M1-aneurysm

 

DPipeline SHIELD DeploymentSA: Right ICA

Pipeline-SHIELD-treatment-of-left-anterior-temporal-mid-M1-aneurysm

 

 

Pipeline SHIELD DeploymentDSA: Left ECA

Pipeline-SHIELD-treatment-of-left-anterior-temporal-mid-M1-aneurysm

 

 

Post-procedure, 1 month

 

Pipeline-SHIELD-treatment-of-left-anterior-temporal-mid-M1-aneurysm

 

  • Patient presented 1 month later with episode of AMS/slurred speech.
  • Briefly patient had been on ASA + Plavix + xarelto until 1/17/23 when she stopped ASA. On arrival to ED the week following, CT/CTP/CTA notable for L BG and anterior temporal strokes with good distal flow beyond stent without significant decrease in cerebral perfusion appreciated.

 

Pipeline-SHIELD-treatment-of-left-anterior-temporal-mid-M1-aneurysm

There is no clear in-stent stenosis. Good wall apposition. There is persistent filling of the aneurysm, but with marked stasis of flow.

Pipeline-SHIELD-treatment-of-left-anterior-temporal-mid-M1-aneurysm

 

There is no clear in-stent stenosis. Good wall apposition. There is persistent filling of the aneurysm, but with marked stasis of flow.

Teaching Points
  • Triple-therapy cessation potential contributing factor
  • Strokes driven by aneurysm pathology
Come and join us across the globe